Table 1.

Treatment Arms

Treatment Arms	Study Reference	Dosage and Treatment Times
Arm 1 (CP)	Ozols et al, 2003 [4]	135 mg/m2 P over 3 hrs + C (AUC 7.5) 21-day cycle × 6
Arm 2 (CP+P)	Markman et al, 2003 [5]	CP as above followed by *175mg/m2 IV P over 3 hrs 28-day cycles × 12
Arm 3 (CPB+B)	Markman et al, 2003 [5]	175 mg/m2 P + C (AUC 6) × 1 cycle 175 mg/m2 P + C (AUC 6) + B 15 mg/kg × 5 cycles B 15 mg/kg × 16 cycles

Note. CP – carboplatin and paclitaxel; CP+P, carboplatin, paclitaxel and paclitaxel maintenance; CPB+B, carboplatin, paclitaxel, bevacizumab, and bevacizumab maintenance; AUC, area under curve